China Shineway Pharmaceutical Group Limited
CSWYF
$0.9398
$0.07378.51%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 14.85M | 14.92M | 43.26M | 43.63M | 33.10M |
| Total Depreciation and Amortization | -830.10K | -834.10K | 5.57M | 5.62M | -1.79M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.71M | -1.72M | -9.88M | -9.96M | 9.41M |
| Change in Net Operating Assets | 15.43M | 15.50M | -- | -- | 1.61M |
| Cash from Operations | 27.73M | 27.87M | 38.95M | 39.29M | 42.33M |
| Capital Expenditure | -4.56M | -4.58M | -5.14M | -5.19M | -6.59M |
| Sale of Property, Plant, and Equipment | 147.00K | 147.70K | 179.20K | 180.70K | 200.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 162.30K | 163.10K | -- | -- | -- |
| Other Investing Activities | -20.19M | -20.29M | 10.46M | 10.55M | 6.64M |
| Cash from Investing | -24.45M | -24.56M | 5.50M | 5.54M | 253.00K |
| Total Debt Issued | 0.00 | 0.00 | 165.00M | 165.00M | 0.00 |
| Total Debt Repaid | -2.11M | -2.11M | -152.03M | -152.03M | -1.85M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.78M | -5.80M | -22.43M | -22.62M | -5.75M |
| Other Financing Activities | -1.71M | -1.71M | -1.43M | -1.43M | -1.21M |
| Cash from Financing | -6.31M | -6.34M | -20.83M | -21.01M | -6.18M |
| Foreign Exchange rate Adjustments | -3.57M | -3.59M | 292.20K | 294.70K | -103.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.59M | -6.62M | 23.90M | 24.11M | 36.30M |